{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:43:54Z","timestamp":1787805834181,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To assess the outcomes of persistent large exudative retinal detachments (ERDs) after proton beam irradiation for choroidal melanoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective study evaluated patients with a diagnosis of ERD in the setting of choroidal melanoma treated with proton beam irradiation at a single academic tertiary center. Inclusion criteria were the presence of an ERD for at least three clock hours at the time of melanoma diagnosis. Data collected included tumor features, management, and visual and anatomical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study comprised 50 eyes of 50 patients with a median age of 51.7 years (range 19.3\u201378.5 years) and a median follow-up of 35.1 months (range 6.6\u2013247.9 months). Thirty-five patients were treated with conservative management, which included observation or intraocular steroids, and 15 patients underwent surgical management with pars plana vitrectomy, drainage of subretinal fluid, endolaser, and silicone oil placement for persistent ERD at a median duration of 7.5 months (range 1.3\u2013117.6 months) after proton beam irradiation. The study found no difference in outcomes of final visual acuity, radiation retinopathy, neovascular glaucoma, and enucleation between conservative and surgical management. Refractory ERD was found to be a significant risk factor for the development of neovascular glaucoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Choroidal melanoma with a large ERD can be successfully treated with conservative or surgical management after proton beam radiation therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004462","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T22:00:08Z","timestamp":1741730408000},"page":"1279-1285","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["OUTCOMES OF PERSISTENT EXUDATIVE RETINAL DETACHMENTS AFTER PROTON BEAM IRRADIATION FOR CHOROIDAL MELANOMA"],"prefix":"10.1097","volume":"45","author":[{"given":"Megan S.","family":"Steinkerchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos S.","family":"Gragoudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-6026","authenticated-orcid":false,"given":"Frances","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250702","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"R2-20250702","first-page":"2085","article-title":"Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance","volume":"42","author":"Kivel\u00e4","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-20250702","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00417-019-04413-z","article-title":"Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy","volume":"257","author":"Hager","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R4-20250702","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archopht.120.11.1463","article-title":"Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma","volume":"120","author":"Harbour","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R5-20250702","doi-asserted-by":"crossref","first-page":"796","DOI":"10.5301\/EJO.2011.6477","article-title":"Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma","volume":"21","author":"Newman","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"R6-20250702","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2012.06.026","article-title":"Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma","volume":"155","author":"Parrozzani","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R7-20250702","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5301\/ejo.5000940","article-title":"Intravitreal dexamethasone implant (Ozurdex\u00ae) for exudative retinal detachment after proton beam therapy for choroidal melanoma","volume":"27","author":"Malcl\u00e8s","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"R8-20250702","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9394(02)02292-4","article-title":"Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments","volume":"136","author":"Char","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R9-20250702","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1442-9071.2009.02127.x","article-title":"Management of exudative retinal detachment in choroidal melanoma","volume":"37","author":"Gibran","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"R10-20250702","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0002-9394(14)76221-X","article-title":"Management of exudative retinal detachment after plaque therapy for intraocular melanoma","volume":"112","author":"Radtke","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R11-20250702","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000365333","article-title":"Endodrainage, tumor photocoagulation, and silicone oil tamponade for primary exudative retinal detachment due to choroidal melanoma persisting after proton beam therapy","volume":"1","author":"Seibel","year":"2014","journal-title":"Ocul Oncol Pathol"},{"key":"R12-20250702","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000233231","article-title":"Clinicopathologic report of uveal melanoma with persistent exudative retinal detachment after gamma knife radiosurgery","volume":"224","author":"Song","year":"2010","journal-title":"Ophthalmologica"},{"key":"R13-20250702","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/IAE.0000000000001337","article-title":"External drainage for primary surgical management of uveal melanoma exudative retinal detachment","volume":"37","author":"McCannel","year":"2017","journal-title":"Retina"},{"key":"R14-20250702","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.oret.2022.05.006","article-title":"A comparison of treatment outcomes after standard dose (70 Gy) versus reduced dose (50 Gy) proton radiation in patients with uveal melanoma","volume":"6","author":"Lane","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R15-20250702","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","article-title":"Proper method for calculating average visual acuity","volume":"13","author":"Holladay","year":"1997","journal-title":"J Refract Surg"},{"key":"R16-20250702","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/2474126420958894","article-title":"Aflibercept for radiation maculopathy (ARM study): year-2 extension of a prospective clinical study","volume":"5","author":"Murray","year":"2021","journal-title":"J Vitreoretin Dis"},{"key":"R17-20250702","first-page":"T2","article-title":"Ranibizumab for the prevention of radiation complications in patients treated with proton beam irradiation for choroidal melanoma","volume":"114","author":"Kim","year":"2016","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R18-20250702","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajo.2014.07.002","article-title":"Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma","volume":"158","author":"Mantel","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R19-20250702","first-page":"193","article-title":"Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment","volume":"7","author":"Houston","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"R20-20250702","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.82.3.213","article-title":"Endoresection of choroidal melanoma","volume":"82","author":"Damato","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R21-20250702","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/eye.2013.115","article-title":"Post-brachytherapy tumor endoresection for treatment of toxic maculopathy in choroidal melanoma","volume":"27","author":"McCannel","year":"2013","journal-title":"Eye (Lond)"},{"key":"R22-20250702","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2013-304501","article-title":"Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy","volume":"98","author":"Konstantinidis","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R23-20250702","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000518976","article-title":"Fatal air embolism after choroidal melanoma endoresection without air infusion: a case report","volume":"7","author":"Rojanaporn","year":"2021","journal-title":"Ocul Oncol Pathol"},{"key":"R24-20250702","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ogla.2022.08.002","article-title":"Incidence and risk factors for secondary glaucoma in eyes with uveal melanoma","volume":"6","author":"Stadigh","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"R25-20250702","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0161-6420(89)32806-5","article-title":"Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings","volume":"96","author":"Shields","year":"1989","journal-title":"Ophthalmology"},{"key":"R26-20250702","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye (Lond)"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:01:03Z","timestamp":1751472063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004462","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}